Subscribe to our newsletter

Raymond H. Hill Joins Corrona as Executive Chairman of Board of Directors

CorEvitas is now part of Thermo Fisher Scientific. Read More.

SOUTHBOROUGH, MA and GREENWICH, CT ― Corrona, a leader in observational data and consulting in the auto-immune field, today announced that Raymond H. Hill has been elected as Executive Chairman of Corrona’s board of directors. Corrona is a portfolio company of the health care investment firm, Great Point Partners, based in Greenwich CT.

As President at InVentiv Health Clinical, a leading contract research organization (CRO), Mr. Hill was instrumental in driving EBITDA growth, securing key strategic partnerships, reducing employee attrition, and re-positioning the company. As President at IMS, Mr. Hill spearheaded work in portfolio strategy, pricing and market access, launch excellence, managed markets, sales force effectiveness, and commercial outsourcing. Mr. Hill also served as the CEO of Pharmaceutical Product Development Inc.